# Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders

> **NCT05791851** · — · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 31 (actual)

## Conditions studied

- HIV Infections
- Hepatitis B
- Vaccine Response Impaired

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05791851
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-23
- **Primary completion:** 2022-06-14
- **Final completion:** 2022-06-14
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05791851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05791851, "Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05791851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*